SCHEMBL7515420

SCHEMBL7515420

Cc1ccccc1C(C([NH])=O)c1ccccc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.45
ACP3 P15309 1/20 0.43
ALDH1A1 P00352 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.38
TSHR P16473 1/20 0.38
ACHE P22303 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
GAA P10253 2/20 0.37
HPGD P15428 2/20 0.36
GLS O94925 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CTSA P10619 1/20 0.34
OPRM1 P35372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22917035 0.80 ESR1 (0.46) ESR1ACP3ALDH1A1L3MBTL1TSHR
SCHEMBL4370114 0.80 ACP3 (0.48) ESR1ACP3ALDH1A1L3MBTL1TSHR
SCHEMBL11215811 0.79 ESR1 (0.42) ESR1ACP3ALDH1A1TSHRACHE
SCHEMBL7723973 0.78 ESR1 (0.45) ESR1ACP3ALDH1A1L3MBTL1TSHR
SCHEMBL23031987 0.75 ESR1 (0.42) ESR1ACP3ALDH1A1L3MBTL1TSHR
SCHEMBL7073828 0.75 ACP3 (0.53) ESR1ACP3ALDH1A1L3MBTL1GAA
SCHEMBL3630774 0.75 ACP3 (0.53) ESR1ACP3ALDH1A1L3MBTL1GAA
SCHEMBL7449447 0.74 ESR1 (0.45) ESR1ACP3ALDH1A1TSHRACHE
SCHEMBL12780403 0.74 ACP3 (0.51) ESR1ACP3ALDH1A1L3MBTL1GAA
SCHEMBL13993318 0.73 ESR1 (0.59) ESR1ACP3ALDH1A1TSHRACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1022274-B1 Intermediates for the preparation of Oxazolidinedione and Thiazolidinedione derivatves SANKYO CO (JP) 2002-08-28 EP disclosed
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed